NPI: 1376994533 · SHAFTER, CA 93263 · 261QU0200X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,480 | $585K |
| 2019 | 35,487 | $1.21M |
| 2020 | 32,942 | $1.04M |
| 2021 | 50,776 | $1.74M |
| 2022 | 71,720 | $2.36M |
| 2023 | 99,595 | $2.66M |
| 2024 | 103,656 | $3.34M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 109,289 | 64,452 | $4.85M | |
| T1015 | Clinic service | 92,043 | 84,398 | $4.35M |
| 99214 | 37,925 | 29,966 | $1.76M | |
| 99203 | 26,110 | 20,168 | $1.33M | |
| 99212 | 9,824 | 5,798 | $398K | |
| 99202 | 5,120 | 3,228 | $201K | |
| 99204 | 277 | 249 | $18K | |
| 87811 | 26,061 | 17,304 | $8K | |
| G0467 | Fqhc visit, estab pt | 139 | 117 | $7K |
| 87804 | 28,218 | 9,687 | $5K | |
| 96372 | 14,669 | 10,315 | $3K | |
| 87650 | 10,963 | 8,151 | $3K | |
| 81002 | 18,117 | 12,994 | $3K | |
| 99215 | Prolong outpt/office vis | 35 | 28 | $2K |
| J1885 | Ketorolac tromethamine inj | 6,425 | 4,438 | $403.39 |
| 87430 | 2,532 | 1,549 | $319.01 | |
| 81025 | 6,493 | 4,577 | $235.22 | |
| 93000 | 673 | 423 | $122.86 | |
| J0696 | Ceftriaxone sodium injection | 3,295 | 2,090 | $120.89 |
| J1100 | Dexamethasone sodium phos | 3,019 | 2,096 | $96.27 |
| G2025 | Dis site tele svcs rhc/fqhc | 12 | 12 | $74.77 |
| J3301 | Triamcinolone acet inj nos | 1,423 | 1,086 | $34.26 |
| 82962 | 246 | 157 | $29.79 | |
| 85018 | 299 | 181 | $21.22 | |
| 99000 | 563 | 556 | $3.63 | |
| 81005 | 399 | 380 | $0.00 | |
| 94640 | 275 | 269 | $0.00 | |
| 99050 | 16 | 16 | $0.00 | |
| 99001 | 1,097 | 1,066 | $0.00 | |
| 69210 | 27 | 14 | $0.00 | |
| 99051 | 72 | 72 | $0.00 |